MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202421028856 A) filed by Dr. Chandrakantsing Vijaysing Pardeshi; Bari Dipak Bhalchandra; and Nikam Tejas Vikram, Shirpur, Maharashtra, on April 9, 2024, for 'an in situ gel formulation of rizatriptan.'
Inventor(s) include Dr. Chandrakantsing Vijaysing Pardeshi; Bari Dipak Bhalchandra; and Nikam Tejas Vikram.
The application for the patent was published on Oct. 10, under issue no. 41/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to pharmaceutical compositions of thermo reversible in situ gel dosage form of rizatriptan for nose to brain drug delivery. The present invention is an in situ gel...